188 related articles for article (PubMed ID: 29781255)
1. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.
Rici REG; Will SEAL; Luna ACL; Melo LF; Santos AC; Rodrigues RF; Leandro RM; Maria DA
Vet Comp Oncol; 2018 Dec; 16(4):478-488. PubMed ID: 29781255
[TBL] [Abstract][Full Text] [Related]
2. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).
Bergman PJ; MacEwen EG; Kurzman ID; Henry CJ; Hammer AS; Knapp DW; Hale A; Kruth SA; Klein MK; Klausner J; Norris AM; McCaw D; Straw RC; Withrow SJ
J Vet Intern Med; 1996; 10(2):76-81. PubMed ID: 8683484
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
[TBL] [Abstract][Full Text] [Related]
4. Update on the biology and management of canine osteosarcoma.
Chun R; de Lorimier LP
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):491-516, vi. PubMed ID: 12852233
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
Inkol JM; Poon AC; Mutsaers AJ
Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
Kozicki AR; Robat C; Chun R; Kurzman ID
Vet Comp Oncol; 2015 Sep; 13(3):229-36. PubMed ID: 23663234
[TBL] [Abstract][Full Text] [Related]
8. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
9. Effects of the potassium-sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells.
Poon AC; Inkol JM; Luu AK; Mutsaers AJ
J Vet Intern Med; 2019 Mar; 33(2):800-811. PubMed ID: 30556178
[TBL] [Abstract][Full Text] [Related]
10. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
York D; Withers SS; Watson KD; Seo KW; Rebhun RB
Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
[TBL] [Abstract][Full Text] [Related]
11. What do we know about canine osteosarcoma treatment? Review.
Szewczyk M; Lechowski R; Zabielska K
Vet Res Commun; 2015 Mar; 39(1):61-7. PubMed ID: 25422073
[TBL] [Abstract][Full Text] [Related]
12. Canine osteosarcoma: amputation and chemoimmunotherapy.
MacEwen EG; Kurzman ID
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
[TBL] [Abstract][Full Text] [Related]
13. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
15. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Morello E; Martano M; Buracco P
Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of P16 expression in canine appendicular osteosarcoma.
Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma.
Withrow SJ; Powers BE; Straw RC; Thrall DE; Gillette EL; LaRue SM; Richter SL
Chir Organi Mov; 1990; 75(1 Suppl):29-31. PubMed ID: 2249550
[No Abstract] [Full Text] [Related]
19. Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma.
Endo-Munoz L; Bennett TC; Topkas E; Wu SY; Thamm DH; Brockley L; Cooper M; Sommerville S; Thomson M; O'Connell K; Lane A; Bird G; Peaston A; Matigian N; Straw RC; Saunders NA
Vet Comp Oncol; 2020 Jun; 18(2):206-213. PubMed ID: 31441983
[TBL] [Abstract][Full Text] [Related]
20. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
